| Topics | Speakers | Time | Venue |
|---|---|---|---|
| EVAR COMPLICATED / RUPTURED AAA | 13.30-14.33 | Session 27 | |
| Endovascular repair of ruptured abdominal aortic aneurysm |
|
13.30 | |
| Open conversion of infected aortic endografts: data from a prospective, multicentre registry |
|
13.35 | |
| Endovascular treatment of ruptured thoracic aneurysm – Single center experience |
|
13.40 | |
| An enhanced recovery protocol for late open conversion after EVAR failure |
|
13.45 | |
| Improved outcomes of open repair of abdominal aneurysm rupture |
|
13.50 | |
| Addressing Type II endoleak after EVAR: an innovative strategy to improve stent-graft stability and reduce the risk of late aneurysm rupture |
|
13.55 | |
| A decade of the GSTT aortic infection programme. Why we should focus more on management algorithm outcomes than comparing treatment options? |
|
14.00 | |
| Discussion | 14.05 | ||
| KEYNOTE LECTURE | Impact of endovascular protocol adoption on ruptured aortic aneurysm outcomes: lessons learned from an institutional analysis |
|
14.23 | |
| SUPRA-AORTIC / CAROTID ARTERIES | 14.35-15.18 | Session 28 | |
| Mini-incision carotid endarterectomy |
|
14.35 | |
| Beyond dogma: strategy-driven stroke prevention in carotid revascularization |
|
14.40 | |
| Completion angiography after carotid endarterectomy is crucial |
|
14.45 | |
| Is it whortwhile treating carotid pseudo-occlusion? |
|
14.50 | |
| Impact of carotid revascularization on cognitive performance |
|
14.55 | |
| CEA in very elderly patients: indications and AI potential role |
|
15.00 | |
| Discussion | 15.05 | ||
| MORE ARTERIAL TOPICS | 15.20-16.33 | Session 29 | |
| Femoral complications of percutaneous access: prevention and treatment |
|
15.20 | |
| Primary outcomes of a BTK sirolimus-eluting bioresorbable vascular scaffold for the treatment of infra-popliteal lesions |
|
15.25 | |
| Lessons from more than 650 CERAB cases in the BeGlory Registry |
|
15.30 | |
| The Semmelweis legacy: lessons learned applicable to vascular and wound care practices |
|
15.35 | |
| Overcoming recoil in BTK interventions: tips and tricks |
|
15.40 | |
| Sirolimus-coated balloon technology for femoro-popliteal arterial disease: current evidence and clinical perspectives |
|
15.45 | |
| Innovation in aortic arch and thoracic treatment: the role of the integrated CO2 protocol in reducing gas embolisms |
|
15.50 | |
| Drug eluting stent in femoropopliteal disease: real-world evidence from a single-center experience |
|
15.55 | |
| Discussion | 16.00 | ||
| KEYNOTE LECTURE | Innovative open and endovascular techniques developed over the years to save hopelessly ischemic lower limbs |
|
||
| VENOUS V | 16.35-17.48 | Session 30 | |
| Stenting for left renal vein compression |
|
16.35 | |
| Venous stenting in oncology patients |
|
16.40 | |
| Twenty years of clinical experience with radiofrequency ablation: evidence, outcomes, and current positioning |
|
16.45 | |
| Mechanical thrombectomy for iliofemoral DVT treatment - Current technology |
|
16.50 | |
| Outcome of stent-graft treatment in the central vein stenosis |
|
16.55 | |
| Our experience in the management of renal tumors with vena cava involvement requiring hepatic vascular exclusion |
|
17.00 | |
| Innovation in stent design applied to ilio-caval reconstruction |
|
17.05 | |
| Cyanoacrylate glue venous truncal ablation - How I do it and 5-year results |
|
17.10 | |
| Discussion | 17.15 | ||
| KEYNOTE LECTURE | Complex surgery of the deep veins |
|
17.38 | |
| FLOW LIMITED ILIAC ARTERY (FLIA) | 17.50-18.13 | Session 31 | |
| Thermography for screening |
|
17.50 | |
| Open surgery for iliac endofibrosis in endurance athletes |
|
17.55 | |
| Redo surgery can bring an Olympic gold |
|
18.00 | |
| Discussion | 18.05 | ||
| AORTA II | 18.15-18.58 | Session 32 | |
| Managing aortic complexity with a new off-the-shelf thoraco-abdominal endoprosthesis: evidence, experience, and technical consideration |
|
18.15 | |
| Aneurysm sac dynamics and its prognostic significance following fenestrated and branched endovascular aortic aneurysm repair |
|
18.20 | |
| From standardization to results: AI in 4-fen physician modified endografts and SPHERE Registry Data |
|
18.25 | |
| Physician-modified and in situ fenestration for visceral aorta repair: combine techniques to overcome challenges |
|
18.30 | |
| Quadruple arch-branch in patients with arteria lusoria |
|
18.35 | |
| Physician modification of commercially available devices to replicate the frozen elephant trunk tecnique |
|
18.40 | |
| Discussion | 18.45 | ||
| Session 33 | |||
| Endovascular management of vascular complications in Ehlers-Danlos Syndrome Type IV |
|
19.00 | |
| Open conversion after failed EVAR is increasing and associated with better survival and reintervention rates to F/B FEVAR |
|
19.05 | |
| How we approach complex aortic repair in Brazil |
|
19.10 | |
| Complex aortic aneurysm repair: the current status in South Africa |
|
19.15 | |
| Physician modified endografts in resources limited settings |
|
19.20 | |
| Techniques for the treatment of hostile necks during EVAR |
|
19.25 | |
| Discussion | 19.30 | ||
| CLOSING REMARKS | 19.42 |